Novo Nordisk A/S

OTC
NONOF
Stock
Yield per half year: -6.67%
Dividend yield: 1.74%
Sector: Healthcare

Novo Nordisk A/S

160.00160.00140.00140.00120.00120.00100.00100.0080.0080.0060.0060.0040.0040.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
27.24 54.24 -49.78% 23.08 +18.03%
P/S 9.47 4.62 104.98%
P/BV 19.17 4.2 356.78%
P/FCF 5.21 16.2 -67.81%
Ev/Ebitda 20.66 14.71 40.46%
Ev/S 9.77 4.05 141.18%
Ev/FCF 40.74 20.97 94.23%
E/P 0.278 1.63 -82.91%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
47.31 25.2 87.73% 47.55 -0.5137%
ROE 80.78 12.46 548.06%
ROA 25.89 6.23 315.38%
ROIC 0 15.34 -100%
ROS 34.78 12.71 173.66%
ROCE 89.79 14.68 511.59%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.7482 6.22 -87.97% 0.4789 +56.24%
Nеt Debt/Ebitda 0.6343 -3.47 -118.26%
Debt/Ratio 0.2207 0.2246 -1.76%
Debt/Equity 2.25 1 124.31%
Debt/Net Income 1.02 18.36 -94.46%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
4.35/10
1.74 2.28 -23.72% 2.38 -26.96%
Number of years of dividend growth 1 1.59 -37.17%
DSI 0.8571 0.7935 8.02%
Average dividend growth -41.12 -303.64 -86.46%
Average percentage for 5 years 2.38 2.59 -8.1%
Average percentage for payments 33.44 167.32 -80.02%
Difference from average difference in sector -0.5411

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
128.76 -98.5 -230.72%
Growth impulse Ebitda in 5 years 128.14 -98.62 -229.93%
Growth impulse Net Income in 5 years 139.66 -98.32 -242.05%
Growth impulse FCF in 5 years 133.21 -98.32 -235.49%
Growth impulse EPS in 5 years 25.71 -82.03 -131.34%
IP Score
6.84/10

Similar companies

Roche Holding

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription